Quarterly Call Option Transactions in Black Diamond Therapeutics, Inc. (BDTX)
This table provides information about the institutional ownership of Black Diamond Therapeutics, Inc. (BDTX) during . The information is specifically focused on institutions that hold call options of Black Diamond Therapeutics, Inc..
Calls Purchased
Calls Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2022 | 69,500 | 0 | 69,500 | — | 69,500 | |||
| Q4 2022 | — | 52,200 | 0 | 52,200 | -52,200 | |||
| Q1 2023 | 0 | 15,500 | 15,500 | 7,300 | 0 | 7,300 | 8,200 | |
| Q2 2023 | 267,500 | 75,500 | 343,000 | — | 343,000 | |||
| Q3 2023 | 0 | 10,000 | 10,000 | 126,600 | 0 | 126,600 | -116,600 | |
| Q4 2023 | — | 149,600 | 0 | 149,600 | -149,600 | |||
| Q1 2024 | 15,100 | 0 | 15,100 | — | 15,100 | |||
| Q2 2024 | 0 | 96,400 | 96,400 | 18,000 | 0 | 18,000 | 78,400 | |
| Q3 2024 | 442,800 | 1,287,100 | 1,729,900 | — | 1,729,900 | |||
| Q4 2024 | — | 5,100 | 0 | 5,100 | -5,100 | |||
| Q1 2025 | 19,200 | 23,000 | 42,200 | — | 42,200 | |||
| Q2 2025 | — | — | 0 | |||||
| Q3 2025 | 0 | 68,700 | 68,700 | — | 68,700 | |||